During the past decade, Haugesund hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haugesund hospital" #1 sponsor was "Haukeland University Hospital" with 3 trials, followed by "Norwegian University of Science and Technology" with 3 trials sponsored, "University of Bergen" with 2 trials sponsored, "Helse Fonna" with 1 trials sponsored and "Hôpital Armand Trousseau" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haugesund hospital" #1 collaborator was "Helse Fonna" with 4 trials as a collaborator, "Karolinska University Hospital" with 3 trials as a collaborator, "Oslo University Hospital" with 3 trials as a collaborator, "Sahlgrenska University Hospital, Sweden" with 3 trials as a collaborator and "St. Olavs Hospital" with 3 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Haugesund hospital" are "Cold Agglutinin Disease" (2 trials), "Small-cell Lung Cancer" (2 trials), "Analgesia" (1 trials), "Autoimmune Hemolytic Anemia" (1 trials) and "Bereavement" (1 trials). Many other conditions were trialed in "Haugesund hospital" in a lesser frequency.

Most popular intervention types in "Haugesund hospital" are "Drug" (7 trials), "Other" (2 trials), "Procedure" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Alteplase" (1 trials), "Atezolizumab" (1 trials), "Bendamustine, Rituximab" (1 trials) and "Bilirubin concentration measured in standard blood samples" (1 trials). Other intervention names were less common.

The vast majority of trials in "Haugesund hospital" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Haugesund hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Haugesund hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Haugesund hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".